Heparin-induced thrombocytopenia with very high antibody titer is associated with slower platelet recovery and higher risk of thrombosis
International Journal of Hematology · 2024
DOI: 10.1007/s12185-024-03811-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Hematology, 2024. Verfasst von Akash Mukherjee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Oncology, Houston Methodist Hospital, Houston, TX, USA. Hauptthemen laut MEDLINE: Heparin, Thrombocytopenia, Thrombosis, Platelet Factor 4. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Abstract (Originalsprache)
Heparin-induced thrombocytopenia (HIT) is a prothrombotic disorder mediated by platelet-activating antibodies targeting platelet factor 4 (PF4) and heparin complex. A higher antibody titer is reflected in a higher optical density (OD) by enzyme-linked immunosorbent assay for heparin-PF4 antibodies. This single-institution retrospective study of 116 HIT patients examined the effect of heparin-PF4 OD on time to platelet recovery, vascular thrombosis, and in-hospital mortality. Patients were divided into 3 cohorts based on heparin-PF4 OD: cohort 1 had an OD ≥ 2 and ≤ 2.4, cohort 2 had an OD > 2.4 and ≤ 2.8, and cohort 3 had an OD > 2.8. A higher OD titer was associated with significantly increased time to platelet recovery when compared between cohorts 1 versus 2 (HR = 0.599, p = 0.0221) and 1 versus 3 (HR = 0.515, p = 0.0014), as well as an increased risk of thrombosis (79.4%-cohort 3 vs 53.8%-cohort 2 vs 46.1%-cohort 1, p = 0.04), but had no impact on mortality (2.62-alive vs 2.65-deceased, p = 0.7432). A higher OD titer can inform risk assessment and support decision-making in HIT patients; however, prospective studies are needed to further clarify the impact of heparin-PF4 OD on outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology and Oncology, Houston Methodist Hospital, Houston, TX, USA.
- Department of Hematology and Oncology, Houston Methodist Hospital, Houston, TX, USA. cggentille@gmail.com.
- Department of Hematology and Oncology, Global Cancer Research Institute, San Jose, CA, USA.
Zitieren
APA
Mukherjee, A., Gentille, C., Patel, A., Ensor, J., & Rice, L. (2024). Heparin-induced thrombocytopenia with very high antibody titer is associated with slower platelet recovery and higher risk of thrombosis. International Journal of Hematology. https://doi.org/10.1007/s12185-024-03811-2
Vancouver
Mukherjee A, Gentille C, Patel A, Ensor J, Rice L. Heparin-induced thrombocytopenia with very high antibody titer is associated with slower platelet recovery and higher risk of thrombosis. International Journal of Hematology. 2024. doi:10.1007/s12185-024-03811-2
BibTeX
@article{Mukherjee2024,
author = {Mukherjee, Akash and Gentille, Cesar and Patel, Asmita and Ensor, Joe and Rice, Lawrence},
title = {Heparin-induced thrombocytopenia with very high antibody titer is associated with slower platelet recovery and higher risk of thrombosis},
journal = {International Journal of Hematology},
year = {2024},
doi = {10.1007/s12185-024-03811-2}
}
EUVIMED